These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12733497)

  • 1. [How to minimize the secondary effects of antiretrovirals].
    Cernadas R
    Sidahora; 2003; (1):8-17. PubMed ID: 12733497
    [No Abstract]   [Full Text] [Related]  

  • 2. Sweetening the toxic cocktail. Managing the side effects of HIV medications.
    Doerfler RE
    Adv Nurse Pract; 2002 May; 10(5):52-4, 57-8, 103. PubMed ID: 12420531
    [No Abstract]   [Full Text] [Related]  

  • 3. Double "d" drug danger.
    Moyle G
    AIDS Read; 2003 Jan; 13(1):15-6, 23-4. PubMed ID: 12569891
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV and insulin resistance in context.
    Kotler DP
    AIDS Read; 2005 May; 15(5):220. PubMed ID: 15900630
    [No Abstract]   [Full Text] [Related]  

  • 5. What does the term "HIV-associated lipodystrophy" mean?
    Marcason W
    J Am Diet Assoc; 2009 Feb; 109(2):364. PubMed ID: 19167963
    [No Abstract]   [Full Text] [Related]  

  • 6. [Side effects of antiretroviral therapy--skin manifestations].
    Esser S
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():8, 10-1. PubMed ID: 19024907
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV-associated lipoatrophy: what are the kinder, gentler agents?
    Dubé MP
    Clin Infect Dis; 2006 Jan; 42(2):281-2. PubMed ID: 16355342
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolic complications of antiretroviral therapy.
    Sweet DE
    Top HIV Med; 2005; 13(2):70-4. PubMed ID: 16082057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Undesirable effects of AIDS treatments].
    Tonnerre P; Delmotte H
    Rev Infirm; 2003 Oct; (94):12-5. PubMed ID: 14621384
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV treatment series II. Part 3 of 4. Managing side effects.
    Fallon SJ
    Posit Aware; 2003; 14(6):28-32. PubMed ID: 14743791
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV lipodystrophy: where are we after ten years?
    Vergel N
    GMHC Treat Issues; 2007; 21(3-4):10-5. PubMed ID: 19230305
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipodystrophy and adrenal insufficiency: potential mediators of peripheral neuropathy in HIV infection?
    Jayakumar P; Shankar EM; Karthikeyan M; Ravikannan P
    Med Hypotheses; 2012 Mar; 78(3):373-6. PubMed ID: 22244839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing issues related to antiretroviral therapy.
    Lesho EP; Gey DC
    Am Fam Physician; 2003 Aug; 68(4):675-86. PubMed ID: 12952384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stigmatization, metabolic trouble, drug resistance: current challenges in HIV therapy].
    Mauss S; Jablonowski H
    MMW Fortschr Med; 2009 Apr; 151(18):28. PubMed ID: 19769068
    [No Abstract]   [Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor gamma agonists and the treatment of HIV-associated lipoatrophy: unraveling the molecular mechanism of their shortcomings.
    Hadigan C
    J Infect Dis; 2008 Dec; 198(12):1729-31. PubMed ID: 18954262
    [No Abstract]   [Full Text] [Related]  

  • 16. Stavudine in antiretroviral therapy: is this the end?
    Brinkman K
    AIDS; 2009 Aug; 23(13):1727-9. PubMed ID: 19571724
    [No Abstract]   [Full Text] [Related]  

  • 17. Beyond lipodystrophy: will toxicity issues ever outweigh the benefits of HAART?
    Vella S; Palmisano L
    J HIV Ther; 2003 May; 8(2):27-8. PubMed ID: 15587479
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic effects of protease inhibitor therapy.
    Bernasconi E
    AIDS Read; 1999 Jul; 9(4):254-6, 259-60, 266-9. PubMed ID: 12737115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention and therapy of HIV-associated lipodystrophy syndrome and antiretroviral caused metabolic changes].
    Mauss S
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():49-53. PubMed ID: 16385875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of zidovudine in development of lipoatrophy.
    Moyle GJ
    AIDS Read; 2005 Nov; 15(11):591-4, 599-600, 603. PubMed ID: 16329181
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.